BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn’s disease. Am J Gastroenterol. 2009;104:2754-2759. [PMID: 19584832 DOI: 10.1038/ajg.2009.387] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Luo FY, Bai AP. Risk of lymphoma after treatment of inflammatory bowel disease with azathioprine. Shijie Huaren Xiaohua Zazhi 2013; 21(22): 2121-2127 [DOI: 10.11569/wcjd.v21.i22.2121] [Reference Citation Analysis]
2 Qiu Y, Chen BL, Feng R, Zhang SH, He Y, Zeng ZR, Ben-Horin S, Peyrin-Biroulet L, Mao R, Chen MH. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease. J Gastroenterol Hepatol 2018;33:664-70. [PMID: 28940780 DOI: 10.1111/jgh.14000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
3 Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR; IBD Cohort Study Group. Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108:1744-1753; quiz 1754. [PMID: 23978953 DOI: 10.1038/ajg.2013.248] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 13.0] [Reference Citation Analysis]
4 Lakatos PL, Kiss LS. Current status of thiopurine analogues in the treatment in Crohn's disease. World J Gastroenterol 2011; 17(39): 4372-4381 [PMID: 22110262 DOI: 10.3748/wjg.v17.i39.4372] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Jakobsen C, Paerregaard A, Munkholm P, Faerk J, Lange A, Andersen J, Jakobsen M, Kramer I, Czernia-Mazurkiewicz J, Wewer V. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009. Inflamm Bowel Dis 2011;17:2541-50. [PMID: 21381152 DOI: 10.1002/ibd.21654] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
6 Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol. 2012;107:579-588. [PMID: 22233693 DOI: 10.1038/ajg.2011.448] [Cited by in Crossref: 157] [Cited by in F6Publishing: 147] [Article Influence: 15.7] [Reference Citation Analysis]
7 Targownik LE, Suissa S. Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research. Am J Gastroenterol 2015;110:1647-50. [PMID: 26323186 DOI: 10.1038/ajg.2015.210] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
8 Kariyawasam VC, Kim S, Mourad FH, Selinger CP, Katelaris PH, Brian Jones D, Mcdonald C, Barr G, Chapman G, Colliwshaw J, Lunney PC, Middleton K, Wang RR, Huang T, Andrews J, Pathirana PW, Leong RW. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019;25:1390-8. [DOI: 10.1093/ibd/izy389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Jeuring SFG, van den Heuvel TRA, Liu LYL, Zeegers MP, Hameeteman WH, Romberg-camps MJL, Oostenbrug LE, Masclee AAM, Jonkers DMAE, Pierik MJ. Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. American Journal of Gastroenterology 2017;112:325-36. [DOI: 10.1038/ajg.2016.524] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 13.8] [Reference Citation Analysis]
10 Targownik LE, Leung S, Lix LM, Singh H, Bernstein CN. Persistence With Immunomodulator Monotherapy Use And Incidence of Therapeutic Ineffectiveness Among Users of Immunomodulator Monotherapy in IBD. Am J Gastroenterol 2018;113:1206-16. [PMID: 29925912 DOI: 10.1038/s41395-018-0108-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Freeman HJ. Natural history and long-term clinical course of Crohn’s disease. World J Gastroenterol 2014; 20(1): 31-36 [PMID: 24415855 DOI: 10.3748/wjg.v20.i1.31] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 56] [Article Influence: 8.5] [Reference Citation Analysis]
12 Mañosa M, Calafat M, de Francisco R, García C, Casanova MJ, Huelín P, Calvo M, Tosca J, Fernández-Salazar L, Arajol C, Zabana Y, Bastida G, Hinojosa J, Márquez L, Barreiro-de-Acosta M, Calvet X, Monfort D, Gómez-Garcia MR, Rodríguez E, Huguet JM, Rojas-Feria M, Hervias D, Atienza R, Busquets D, Zapata E, Dueñas C, Charro M, Martínez-Cerezo FJ, Plaza R, Vázquez JM, Gisbert JP, Cañete F, Cabré E, Domènech E; GETECCU. Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study. Aliment Pharmacol Ther 2018;47:605-14. [PMID: 29369387 DOI: 10.1111/apt.14494] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
13 Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of patients with Crohn’s disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology. 2011;141:90-97. [PMID: 21458455 DOI: 10.1053/j.gastro.2011.03.050] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 10.2] [Reference Citation Analysis]
14 Burr NE, Lord R, Hull MA, Subramanian V. Decreasing Risk of First and Subsequent Surgeries in Patients with Crohn's Disease in England From 1994 through 2013. Clin Gastroenterol Hepatol. 2019;17:2042-2049.e4. [PMID: 30583051 DOI: 10.1016/j.cgh.2018.12.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Targownik LE, Nugent Z, Singh H, Bernstein CN. Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:622-30. [DOI: 10.1097/mib.0000000000000008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
16 Khoudari G, Mansoor E, Click B, Alkhayyat M, Saleh MA, Sinh P, Katz J, Cooper GS, Regueiro M. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study. Clinical Gastroenterology and Hepatology 2020. [DOI: 10.1016/j.cgh.2020.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
17 Chatu S, Subramanian V, Saxena S, Pollok RC. The role of thiopurines in reducing the need for surgical resection in Crohn’s disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:23-34; quiz 35. [PMID: 24322839 DOI: 10.1038/ajg.2013.402] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
18 Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, Jess T. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut. 2014;63:1607-1616. [PMID: 24056767 DOI: 10.1136/gutjnl-2013-305607] [Cited by in Crossref: 205] [Cited by in F6Publishing: 195] [Article Influence: 22.8] [Reference Citation Analysis]
19 Burr NE, Smith C, West R, Hull MA, Subramanian V. Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. Clin Gastroenterol Hepatol 2018;16:534-541.e6. [PMID: 29079223 DOI: 10.1016/j.cgh.2017.10.022] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
20 Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis 2012;18:2225-31. [PMID: 22359399 DOI: 10.1002/ibd.22925] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
21 Harper JW, Welch MP, Sinanan MN, Wahbeh GT, Lee SD. Co-morbid diabetes in patients with Crohn’s disease predicts a greater need for surgical intervention: Co-morbid diabetes in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics 2012;35:126-32. [DOI: 10.1111/j.1365-2036.2011.04915.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Fujita T. Level of evidence supporting the use of thiopurine in Crohn's disease. Am J Gastroenterol 2014;109:1497. [PMID: 25196879 DOI: 10.1038/ajg.2014.191] [Reference Citation Analysis]
23 Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy. European Journal of Gastroenterology & Hepatology 2015;27:175-81. [DOI: 10.1097/meg.0000000000000244] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 4.9] [Reference Citation Analysis]
24 Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn’s disease after first intestinal surgery. Am J Gastroenterol. 2010;105:1158-1164. [PMID: 20010925 DOI: 10.1038/ajg.2009.673] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
25 Kim M, Choi KH, Hwang SW, Lee YB, Park HJ, Bae JM. Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: A population-based cross-sectional study. Journal of the American Academy of Dermatology 2017;76:40-8. [DOI: 10.1016/j.jaad.2016.08.022] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
26 Egberts JH, Stroeh A, Alkatout I, Goumas FA, Brand PA, Schafmayer C, Becker T, Schniewind B. Preoperative risk evaluation of postoperative morbidity in IBD patients--impact of the POSSUM score. Int J Colorectal Dis 2011;26:783-92. [PMID: 21526374 DOI: 10.1007/s00384-011-1179-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
27 Sato Y, Matsui T, Yano Y, Tsurumi K, Okado Y, Matsushima Y, Koga A, Takahashi H, Ninomiya K, Ono Y, Takatsu N, Beppu T, Nagahama T, Hisabe T, Takaki Y, Hirai F, Yao K, Higashi D, Futami K, Washio M. Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol. 2015;30:1713-1719. [PMID: 26094852 DOI: 10.1111/jgh.13013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
28 Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011;15:267-276. [PMID: 21108015 DOI: 10.1007/s11605-010-1396-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
29 Jeuring SFG, Bours PHA, Zeegers MP, Ambergen TW, van den Heuvel TR, Romberg-camps MJL, van Bodegraven AA, Oostenbrug LE, Breukink SO, Stassen LPS, Hameeteman WH, Masclee AAM, Jonkers DMAE, Pierik MJ. Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort. ECCOJC 2015;9:837-45. [DOI: 10.1093/ecco-jcc/jjv129] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
30 Chen M, Remer EM, Liu X, Lopez R, Shen B. Identification of the distinguishing features of Crohn's disease and ischemic colitis using computed tomographic enterography. Gastroenterol Rep (Oxf) 2017;5:219-25. [PMID: 28852526 DOI: 10.1093/gastro/gow037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785-1794. [PMID: 21530745 DOI: 10.1053/j.gastro.2011.01.055] [Cited by in Crossref: 1157] [Cited by in F6Publishing: 1053] [Article Influence: 105.2] [Reference Citation Analysis]
32 Golovics PA, Lakatos PL, Dávid G, Pandur T, Erdélyi Z, Horváth Á, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Lovász BD, Szathmári M, Kiss LS, Lakatos L. The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron’s disease, in Veszprém county, Hungary, a population-based cohort study. Orvosi Hetilap 2012;153:541-52. [DOI: 10.1556/oh.2012.29331] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Ideström M, Rubio CA, Onelöv E, Henter J, Fagerberg UL, Finkel Y. Pediatric Crohn’s disease from onset to adulthood: granulomas are associated with an early need for immunomodulation. Scandinavian Journal of Gastroenterology 2014;49:950-7. [DOI: 10.3109/00365521.2014.920911] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
34 Frei R, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study. J Crohns Colitis 2019;13:1292-301. [PMID: 30854548 DOI: 10.1093/ecco-jcc/jjz057] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
35 Church PC, Turner D, Feldman BM, Walters TD, Greer ML, Amitai MM, Griffiths AM; ImageKids Study Group. Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease. Aliment Pharmacol Ther 2015;41:153-66. [PMID: 25403954 DOI: 10.1111/apt.13024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
36 Frolkis AD, de Bruyn J, Jette N, Lowerison M, Engbers J, Ghali W, Lewis JD, Vallerand I, Patten S, Eksteen B, Barnabe C, Panaccione R, Ghosh S, Wiebe S, Kaplan GG. The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis. Clin Transl Gastroenterol 2016;7:e165. [PMID: 27101004 DOI: 10.1038/ctg.2016.21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
37 Ha C, Dassopoulos T. Thiopurine therapy in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010;4:575-588. [PMID: 20932143 DOI: 10.1586/egh.10.59] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
38 Chhaya V, Pollok R. The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? F1000Prime Rep 2013;5:50. [PMID: 24273651 DOI: 10.12703/P5-50] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Chen M, Yi F, Zhou F, Huang M, Li J, Yan W, Li L, Xia B. Risk factors for initial surgery in patients with Crohn's disease in Central China. Surg Today 2015;45:1002-8. [PMID: 25524561 DOI: 10.1007/s00595-014-1093-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 To N, Gracie DJ, Ford AC. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Aliment Pharmacol Ther. 2016;43:549-561. [PMID: 26749371 DOI: 10.1111/apt.13511] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 14.7] [Reference Citation Analysis]
41 Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 2021;160:1452-1460.e21. [PMID: 33421515 DOI: 10.1053/j.gastro.2020.10.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
42 Banerjee R, Pal P, Girish BG, Reddy DN. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region? Aliment Pharmacol Ther 2018;47:1367-74. [DOI: 10.1111/apt.14617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
43 Chatu S, Saxena S, Subramanian V, Curcin V, Yadegarfar G, Gunn L, Majeed A, Pollok RC. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010. Am J Gastroenterol 2014;109:409-16. [PMID: 24469612 DOI: 10.1038/ajg.2013.462] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
44 de Souza GS, Vidigal FM, Chebli LA, da Rocha Ribeiro TC, Furtado MC, de Lima Pace FH, de Miranda Chaves LD, de Oliveira Zanini KA, Gaburri PD, de Azevedo Lucca F, Zanini A, Ribeiro LC, Chebli JM. Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients. Med Sci Monit 2013;19:716-22. [PMID: 23989915 DOI: 10.12659/MSM.889196] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
45 Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflamm Bowel Dis 2016;22:1647-54. [PMID: 27271489 DOI: 10.1097/MIB.0000000000000828] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]